Co-Diagnostics (CODX) Expands CoSara Distribution Territory Across South Asia
2 Articles
2 Articles
Co-Diagnostics (CODX) Expands CoSara Distribution Territory Across South Asia
LOS ANGELES, CA - March 20, 2026 (NEWMEDIAWIRE) - Co-Diagnostics (NASDAQ: CODX) announced that its Indian joint venture, CoSara Diagnostics Pvt. Ltd., has signed an agreement to expand its commercial and distribution territory across South Asia to include Bangladesh, Pakistan, Nepal and Sri Lanka, significantly increasing its addressable market to an estimated $13.0 billion. The expansion supports planned commercialization of the CoSara PCR Pro(…
Co-Diagnostics inks agreement to expand distribution across South Asia - BioTuesdays
Co-Diagnostics (NASDAQ: CODX) has signed an agreement for closely held CoSara Diagnostics—the Indian joint venture between Co-Dx and Ambalal Sarabhai—to significantly expand its commercial and distribution territory across South Asia to now include Bangladesh, Pakistan, Nepal, and Sri Lanka. The expansion significantly increases CoSara’s addressable market across South Asia, bringing the total regional opportunity to an estimated $13.0 billion b…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium